基于循环谱理论的BPSK直扩信号检测

研究了扩频信号的周期平稳性及其循环谱密度函数;在推导出BPSK扩频信号的循环谱密度函数的基础上,提出利用循环谱理论对BPSK直扩信号进行检测,并用MATLAB进行仿真验证。     

DC/DC电源中的电磁干扰及其对策

概述了电磁干扰(EMI)和电磁兼容(EMC)的基本知识，对DC／DC电源中的电磁干扰进行了综合分析，并给出了各自的解决方案。     

MEMS封装技术研究进展

介绍了MEMS封装技术的特点、材料以及新技术,包括单片全集成MEMS封装、多芯片组件(MCM)封装、倒装芯片封装、准密封封装和模块式MEMS封装等。文中还介绍了MEMS产品封装实例。     

原位插层聚合制备PVC/蒙脱土纳米复合材料

采用氯乙烯单体直接插层到蒙脱土中进行原位插层聚合，制备纳米复合材料，并用小角X射线衍射（XRD）、扫描电子显微镜（SEM）和电子探针技术对复合材料进行了结构表征。实验结果表明：采用原位插层聚合法制得的PVC／蒙脱土（MMT）复合材料为剥离型纳米复合材料。     

济钢中厚板厂3500mm精轧机快速换辊自控系统

中厚板厂3500mm精轧机快速换辊自控系统，集可编程序控制器、变频传动技术、液压控制于一体。实现了工作辊、支承辊准确、快速地更换。通过网络技术与其他控制系统进行数据交换、操作及连锁，使轧制生产线实现了全自动化轧制，不仅改善了工人的劳动强度，还提高了产品的产量及质量，取得了巨大的社会效益及经济效益。     

自适应抗干扰系统在引信中的应用

为了提高无线电引信的抗干扰性能,研究以自适应天线技术为基础的引信抗干扰系统.根据信号与干扰的具体环境,灵活地控制天线的参数,自动调节方向图,使其零点自适应地对准干扰方向,以实现在空间上对信号的最佳接收和对干扰的有效抑制.     

Insertion/deletion polymorphism in the angiotensin-converting enzyme gene associated with macroangiopathy and blood pressure in patients with non-insulin-dependent diabetes mellitus

In the search for new risk factors for diabetic macroangiopathy the insertion/deletion (I/D) polymorphism in the angiotensin-converting enzyme gene was studied in 237 consecutive patients (125 men and 112 women) with non-insulin-dependent diabetes. The female population showed an excess of ischemic electrocardiographic changes or definite myocardial infarctions in the patients homozygous for the deletion [D/D; odds ratio (OR) 2.8; 95% confidence interval (CI) 1.4-5.3] and in the insertion/deletion heterozygotes (I/D; OR 1.8; CI 1.1-3.1) compared with the patients homozygous for the insertion (I/I). In the total series coronary heart disease, cerebrovascular disease, and claudication were more often observed in the patients with I/D (OR 1.5; CI 1.0-2.2) or the D/D genotype patients (OR 1.7; CI 1.1-2.6) than in those with the genotype I/I. The systolic blood pressure was lower in patients with genotype I/I (138 +/- 19 mmHg) than in those with the genotype I/D (149 +/- 22 mmHg) or D/D (150 +/- 21 mmHg; P < 0.02). The prevalence of hypertension and the median urinary albumin excretion rate also tended to be lowest in the I/I genotype patients. Multiple logistic analysis revealed that in women the angiotensin-converting enzyme D/D genotype is independently associated with coronary heart disease. Our findings suggest that variation at the angiotensin-converting enzyme gene locus is one of the factors involved in the predisposition of diabetic patients to the development of arterial disease and hypertension.     

Perturbation in the 240Pu/239Pu global fallout ratio in local sediments following the nuclear accidents at Thule (Greenland) and Palomares (Spain)

Diabetes complicates 2-3% of all pregnancies and is associated with an increase in both perinatal morbidity and mortality, though reasons for these adverse outcomes are unknown. Estrogen biosynthesis is a critical factor during pregnancy and is carried out in the placenta via aromatase (cytochrome P450 19A1), which catalyzes the conversion of C-19 androgens to C-18 estrogens. Previous studies have shown that hormones such as insulin-like growth factors and insulin regulate aromatase activity when studied in vitro. Interestingly, levels of these hormones are altered in patients with diabetes. Thus, we hypothesized that the presence of maternal diabetes may alter placental aromatase activity and thus estrogen biosynthesis, possibly serving as one factor in the adverse outcomes of babies born to mothers with diabetes. To this end, we measured the production of 19-hydroxyandrostenedione, 19-oxoadrostenedione and estrone in 30 placental tissues from diabetic patients, using [7-3H]androst-4-ene-3,17-dione as a model substrate for aromatase (P450 19A1). A statistical difference was detected in the percentage of 19-oxoandrostenedione formed between the overt and control groups (P < 0.05). Additionally, NADPH P450-reductase levels were measured in these same tissues to determine whether alterations in this enzyme necessary for aromatase activity could be affected by diabetes. No differences in reductase levels were detected among the patient groups. However, a statistical correlation was found between NADPH P450-reductase activity and the formation velocities of all three estrogen products (P < 0.05). Thus, it appears that the presence of diabetes does not affect placental aromatase activity.     

地震数据采集系统中频谱均衡滤波器的理论设计

地层的高频吸收衰减效应是导致地震勘探分辨率不高的主要原因，在高分辨率野外地震数据系统中，频谱均衡滤波器所设置的重要部件。文章以频谱均衡滤波器的原理和地层吸收衰减特性为基础，用计算机模拟的方法研究地层吸收衰减使分辨率降低的程度和频谱均衡滤波器对分辨率的补偿效果，给出了较好的频谱均衡滤波器的设计方案。     

The lack of long-term detrimental effects on liver allografts caused by donor-specific anti-HLA antibodies

Recent reports indicate a higher incidence of both acute and chronic liver allograft rejection when, at the time of transplantation, the recipients serum contains donor-specific anti-HLA antibodies. From 9/89 to 5/91, 133 liver allografts were performed at our institution. Thirteen liver recipients had donor-specific IgG anti-HLA antibodies (complement-fixing) at the time of transplantation. In eleven patients, antibodies reacted to donor class I antigens while in 1 patient the donor-specific antibody had class II reactivity. Twelve patients have been followed for a minimum of 12 months (median 18 months, range 28-12 months). No hyperacute rejection was seen in any of the cases and four patients had acute rejections. Thus far only one of the twelve patients has biopsy evidence suggestive of chronic liver injury. The remaining have normal liver enzymes and bilirubin. Three of these twelve patients died (one from a myocardial infarction and the others from sepsis) accounting for a one-year graft survival of 75%. There was no significant statistical difference in the one-year graft survival in those recipients without donor-specific antibodies (i.e., 80.5%). In eight of the twelve patients, pretransplant preformed antibody level (PRA) was > 50%. In six of the thirteen patients donor-specific antibody was present at dilutions greater than 1:64. As previously reported, the donor-specific antibody disappeared from the serum posttransplant within hours and did not reappear. In vitro studies demonstrated no factor in portal or hepatic artery blood that could inhibit rabbit complement mediated lysis of anti-HLA antibodies. We conclude that it is not a contraindication to do liver transplants in the presence of donor-specific anti-HLA antibodies.